Health and Healthcare
5864 Articles
Medical devices was supposed to be recession-proof, or at least was supposed to be recession-resistant. But we have seen over…
If we told you on Friday that a decent-sized medical merger was coming with a 100% premium, you probably wouldn’t…
La Jolla Pharmaceutical Company (NASDAQ: LJPC) has been more than just a troubled biotech. It has even been considered an…
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT…
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) is responding well in pre-market trading after the company signed an overseas commercialization agreement with…
Biogen Idec Inc. (NASDAQ: BIIB) just came out with an SEC filing showing that on December 11, 2008, regulatory agencies…
Amylin Pharmaceuticals, Inc., (NASDAQ: AMLN) has been a battered biotech lately. But shares have just now gotten back above the…
It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally…
Merck & Co., Inc. (NYSE: MRK) today outlined its drug pipeline and has reaffirmed its guidance given last week. Merck…
Generally speaking, we do not like to bring CEOs back from a past "list of CEOs to go." James Tobin…
So much fore feeling better in a bad economy. Merck (MRK) offered lackluster guidance for next year and the stock…
UnitedHealth Group Inc. (NYSE: UNH) has made some rather bold predictions for 2009. What is interesting here is that these…
If you thought that high-premium buyouts or M&A was dead, that is not the case in at least some opportunities. …
ZymoGenetics, Inc. (NASDAQ: ZGEN) has filed an SEC registration which would allow the company to sell up to $100 million…
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) has filed to sell up to 25 million shares of common stock in a public…
Our top personal finance-related articles today. Your wallet will thank you later.